Sarah C. Glover

Sarah C. Glover

Professor

Department:
SOM-Medicine

Email:
scglover@umc.edu

Work Phone:
(601) 984-4540

Biography

Dr. Sarah Glover grew up in the Pacific Northwest, obtained a Bachelor of Arts in chemistry at Seattle Pacific University, and received her medical degree from Midwestern University in Chicago, Illinois. Dr. Glover completed her Internal Medicine Residency and GI fellowship at the University of Illinois at Chicago and then joined their faculty from 2004 to 2010. From 2011 until 2018, she served as faculty at the University of Florida in Gainesville. Since January 2019, Dr. Glover has served as the Division Chief for Digestive Diseases at the University of Mississippi Medical Center in Jackson.

Dr. Glover’s clinical practice is focused on the medical management of Crohn’s Disease, ulcerative colitis, eosinophilic and mast cell disorders that impact the GI tract including hereditary alpha tryptasemia. Dr. Glover has current collaborative NIH funding and is active in industry-sponsored clinical trials. Her laboratory focuses on innate immune mechanisms of gut inflammation and COVID-19 immune responses.

Education

Midwestern University, DO, Doctor of Osteopathic Medicine1998
Seattle Pacific University, BA, chemistry1994

Specialty Certification Licensure

Licensure, Doctor of Osteopathic Medicine, Mississippi State Board of Medical Licensure12/2018 - 06/2020
Certification, American Board of Internal Medicine11/2004 - Present

Current Positions

Professor, School of Medicine, Department of Medicine09/2022 - Present
The University of Mississippi Medical Center
Jackson, Mississippi 39216

Academic Appointments or Other Previous Appointments

Division Director, University of Mississippi Medical Center, School of Medicine, Department of Medicine01/2019 - 09/2022
Adjunct Associate Professor, University of Florida, School of Medicine, Department of Medicine01/2019 - 2020
Associate Professor, University of Florida, School of Medicine, Department of Medicine06/2013 - 01/2019
Assistant Professor, University of Florida, School of Medicine, Department of Medicine2011 - 05/2013
Assistant Professor, University of Illinois at Chicago, School of Medicine, Department of Medicine06/2004 - 12/2010

Sponsored Program Funding

Extramural, Clinical and Pre-Clinical Predictors of Response to Gattex in Short Bowel Syndrome, Takeda01/2020 - 01/2022
Extramural, R21 DE028378-01A1 Innate Immune Mechanisms of Peridontal Disease in Inflammatory Bowel Disease, National Institute of Dental and Craniofacial Research09/2019 - 08/2021
Extramural, A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Crohn's Disease, Bristol Myers Squibb06/2019 - 05/2021
Extramural, R01DK073338 Role of Bacteria in Colitis-Associated Colon Cancer, National Institute of Diabetes and Digestive and Kidney07/2018 - 01/2019
Extramural, R21 TR002639-01A1 Repurposing Pharmacological Agents for Inherited Mast Cell Disorders of the Gut, NCATS09/2017 - 06/2021
Extramural, Pfizer Pilot Research Award in Inflammatory Bowel Disease: Defective STAT3 Signaling in Inflammatory Bowel Disease, American Gastroenterological Association07/2017 - 06/2018
Extramural, RO1 CA113975 PI Glover Role of Surface Roughness in Regulating Tumor Cell Behavior, National Cancer Institute09/2008 - 06/2013
Extramural, T32 DK007788-03 Molecular Training in Gastroenterology and Heptaology, National Institute of Diabetes and Digestive Health08/2000 - 06/2005

Publications

Letter

Mendoza Alvarez LB, Barker R, Nelson C, DiMaggio T, Stone KD, Milner JD, Rosenthal JA, Petroni DH, Glover SC, Lyons JJ, Clinical response to omalizumab in patients with hereditary α-tryptasemia. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2020 Jan;124(1):99-100.e12020
Navaneethan U, Edminister T, Zhu X, Kommaraju K, Glover S, Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases, 2017 Apr;23(4):E172017
Li J, Shouval DS, Doty AL, Snapper SB, Glover SC, Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakin Treatment Suggests Further Mechanism for Mucosal Healing. Journal of clinical immunology, 2017 Feb;37(2):104-1072017

Journal Article

Osterman MT, VanDussen KL, Gordon IO, Davis EM, Li K, Simpson K, Ciorba M, Glover SC, Abraham B, Guo X, Yee EU, Allard FD, Perrigoue JG, Claggett B, Shen B, Stappenbeck TS, Liu JJ, Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn's Disease. Inflammatory bowel diseases, 2021 Apr 15;27(5):677-6852021
Liu JJ, Sloan ME, Owings AH, Figgins E, Gauthier J, Gharaibeh R, Robinson T, Williams H, Sindel CB, Backus F, Ayyalasomayajula K, Parker A, Senitko M, Abraham GE 3rd, Claggett B, Horwitz BH, Jobin C, Adelman RM, Diamond G, Glover SC, Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy. The American journal of gastroenterology, 2021 Aug 1;116(8):1638-16452021
Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Christian T, Parker A, Sindel CB, Burger MW, Pride Y, Hasan M, Abraham GE 3rd, Senitko M, Robinson TO, Shalek AK, Glover SC, Horwitz BH, Ordovas-Montanes J, Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. bioRxiv : the preprint server for biology, 2021 Feb 20;2021
Konnikova L, Robinson TO, Owings AH, Shirley JF, Davis E, Tang Y, Wall S, Li J, Hasan MH, Gharaibeh RZ, Mendoza Alvarez LB, Ryan LK, Doty A, Chovanec JF, O'Connell MP, Grunes DE, Daley WP, Mayer E, Chang L, Liu J, Snapper SB, Milner JD, Glover SC, Lyons JJ, Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia. The Journal of allergy and clinical immunology, 2021 Sep;148(3):813-821.e72021
Hamilton MJ, Zhao M, Giannetti MP, Weller E, Hufdhi R, Novak P, Mendoza-Alvarez LB, Hornick J, Lyons JJ, Glover SC, Castells MC, Pozdnyakova O, Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome. The American journal of surgical pathology, 2021 Jul 1;45(7):997-10042021
Moon N, Aryan M, Westerveld D, Nathoo S, Glover S, Kamel AY, Clinical Manifestations of Copper Deficiency: A Case Report and Review of the Literature. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2021 Oct;36(5):1080-10852021
Osterman MT, Gordon IO, Davis EM, Ciorba M, Glover SC, Abraham B, Khan F, Guo X, Yee EU, Allard FD, Claggett B, Shen B, Liu JJ, Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease. Inflammatory bowel diseases, 2020 Sep 18;26(10):1554-15612020
Johnson AN, Harkema JR, Nelson AJ, Dickinson JD, Kalil J, Duryee MJ, Thiele GM, Kumar B, Singh AB, Gaurav R, Glover SC, Tang Y, Romberger DJ, Kielian T, Poole JA, MyD88 regulates a prolonged adaptation response to environmental dust exposure-induced lung disease. Respiratory research, 2020 Apr 22;21(1):972020
Mendoza Alvarez LB, Liu X, Glover S, Treatment-resistant eosinophilic oesophagitis successfully managed with tofacitinib. BMJ case reports, 2019 Dec 11;12(12)2019
Danese S, Sandborn WJ, Colombel JF, Vermeire S, Glover SC, Rimola J, Siegelman J, Jones S, Bornstein JD, Feagan BG, Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease. Gastroenterology, 2019 Oct;157(4):1007-1018.e72019
Chen C, Hartzema AG, Xiao H, Wei YJ, Chaudhry N, Ewelukwa O, Glover SC, Zimmermann EM, Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy. Inflammatory bowel diseases, 2019 Jul 17;25(8):1417-14272019
Ayoub F, Kamel AY, Ouni A, Chaudhry N, Ader Y, Tan S, Iqbal A, Zimmermann EM, Glover SC, Pre-operative total parenteral nutrition improves post-operative outcomes in a subset of Crohn's disease patients undergoing major abdominal surgery. Gastroenterology report, 2019 Apr;7(2):107-1142019
Schwimmer D, Glover S, Primary Immunodeficiency and the Gut. Gastroenterology clinics of North America, 2019 Jun;48(2):199-2202019
Glover SC, Nouri MZ, Tuna KM, Mendoza Alvarez LB, Ryan LK, Shirley JF, Tang Y, Denslow ND, Alli AA, Lipidomic analysis of urinary exosomes from hereditary α-tryptasemia patients and healthy volunteers. FASEB bioAdvances, 2019 Oct;1(10):624-6382019
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C, UNIFI Study Group, Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. The New England journal of medicine, 2019 Sep 26;381(13):1201-12142019
Li J, Glover SC, Innate Lymphoid Cells in Inflammatory Bowel Disease. Archivum immunologiae et therapiae experimentalis, 2018 Dec;66(6):415-4212018
Ewelukwa O, Perez R, Carter LE, Fernandez A, Glover S, Incorporation of Scribes Into the Inflammatory Bowel Disease Clinic Improves Quality of Care and Physician Productivity. Inflammatory bowel diseases, 2018 Feb 15;24(3):552-5572018
Kamel AY, Ayoub F, Banerjee D, Chaudhry N, Ader Y, Tan S, Zimmermann EM, Glover SC, Iqbal A, Effects of Preoperative Use of Biologic Agents on Operative Outcomes in Crohn's Disease Patients. The American surgeon, 2018 Sep 1;84(9):1526-15302018
Shouval DS, Konnikova L, Griffith AE, Wall SM, Biswas A, Werner L, Nunberg M, Kammermeier J, Goettel JA, Anand R, Chen H, Weiss B, Li J, Loizides A, Yerushalmi B, Yanagi T, Beier R, Conklin LS, Ebens CL, Santos FGMS, Sherlock M, Goldsmith JD, Kotlarz D, Glover SC, Shah N, Bousvaros A, Uhlig HH, Muise AM, Klein C, Snapper SB, Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD. Inflammatory bowel diseases, 2017 Nov;23(11):1950-19612017
Westerveld D, Li J, Glover S, Oesophageal mastocytosis: eosinophilic oesophagitis without eosinophils? BMJ case reports, 2017 Aug 28;20172017
Afrin LB, Fox RW, Zito SL, Choe L, Glover SC, Successful targeted treatment of mast cell activation syndrome with tofacitinib. European journal of haematology, 2017 Aug;99(2):190-1932017
Westerveld D, Grajo J, Beattie L, Glover S, Vedolizumab: a novel medical intervention in the treatment of primary sclerosing cholangitis. BMJ case reports, 2017 May 13;20172017
Unnikrishnan A, Glover SC, Norkina O, Wingard JR, Norkin M, Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide. Bone marrow transplantation, 2017 Aug;52(8):1204-12052017
Li J, Doty AL, Tang Y, Berrie D, Iqbal A, Tan SA, Clare-Salzler MJ, Wallet SM, Glover SC, Enrichment of IL-17A(+) IFN-γ(+) and IL-22(+) IFN-γ(+) T cell subsets is associated with reduction of NKp44(+) ILC3s in the terminal ileum of Crohn's disease patients. Clinical and experimental immunology, 2017 Oct;190(1):143-1532017
Li J, Shouval DS, Doty AL, Snapper SB, Glover SC, Erratum to: Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakinra Treatment Suggests Further Mechanism for Mucosal Healing. Journal of clinical immunology, 2017 Feb;37(2):1082017
Lyons JJ, Yu X, Hughes JD, Le QT, Jamil A, Bai Y, Ho N, Zhao M, Liu Y, O'Connell MP, Trivedi NN, Nelson C, DiMaggio T, Jones N, Matthews H, Lewis KL, Oler AJ, Carlson RJ, Arkwright PD, Hong C, Agama S, Wilson TM, Tucker S, Zhang Y, McElwee JJ, Pao M, Glover SC, Rothenberg ME, Hohman RJ, Stone KD, Caughey GH, Heller T, Metcalfe DD, Biesecker LG, Schwartz LB, Milner JD, Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nature genetics, 2016 Dec;48(12):1564-15692016
Shouval DS, Biswas A, Kang YH, Griffith AE, Konnikova L, Mascanfroni ID, Redhu NS, Frei SM, Field M, Doty AL, Goldsmith JD, Bhan AK, Loizides A, Weiss B, Yerushalmi B, Yanagi T, Lui X, Quintana FJ, Muise AM, Klein C, Horwitz BH, Glover SC, Bousvaros A, Snapper SB, Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. Gastroenterology, 2016 Dec;151(6):1100-11042016
Nathoo S, Hood WA, Keihanian S, Collinsworth AL, Glover SC, Tofacitinib for the treatment of tumor necrosis factor-α inhibitor refractory esophageal Crohn's disease: a case report. Journal of medical case reports, 2016 Sep 23;10(1):2642016
Kamel AY, Concepcion O, Schlachterman A, Glover S, Forsmark CY, Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease. ACG case reports journal, 2016 Apr;3(3):187-92016
Westerveld D, Patel A, Drane W, Glover S, Coming full circle: an impressive case of Crohn's disease. BMJ case reports, 2016 Feb 17;20162016
Li J, Bharadwaj SS, Guzman G, Vishnubhotla R, Glover SC, ROCK I Has More Accurate Prognostic Value than MET in Predicting Patient Survival in Colorectal Cancer. Anticancer research, 2015 Jun;35(6):3267-732015
Coman RM, Glover SC, Gjymishka A, Febrile pleuropericarditis, a potentially life-threatening adverse event of balsalazide--case report and literature review of the side effects of 5-aminosalicylates. Expert review of clinical immunology, 2014 May;10(5):667-752014
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A, GEMINI 2 Study Group, Vedolizumab as induction and maintenance therapy for Crohn's disease. The New England journal of medicine, 2013 Aug 22;369(8):711-212013
Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A, GEMINI 1 Study Group, Vedolizumab as induction and maintenance therapy for ulcerative colitis. The New England journal of medicine, 2013 Aug 22;369(8):699-7102013
Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT, Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013 Mar;11(3):286-92; quiz e242013
Rapier R, Huq J, Vishnubhotla R, Bulic M, Perrault CM, Metlushko V, Cho M, Tay RT, Glover SC, The extracellular matrix microtopography drives critical changes in cellular motility and Rho A activity in colon cancer cells. Cancer cell international, 2010 Jul 28;10:242010
Vishnubhotla R, Sun S, Huq J, Bulic M, Ramesh A, Guzman G, Cho M, Glover SC, ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Laboratory investigation; a journal of technical methods and pathology, 2007 Nov;87(11):1149-582007
Tang Y, Tan SA, Iqbal A, Li J, Glover SC, STAT3 Genotypic Variant rs744166 and Increased Tyrosine Phosphorylation of STAT3 in IL-23 Responsive Innate Lymphoid Cells during Pathogenesis of Crohn's Disease. Journal of immunology research, 2019;2019:9406146
Zhang D, Glover SC, Liu W, Liu X, Lai J, Small Bowel Pyogenic Granuloma With Cytomegalovirus Infection in a Patient With Crohn's Disease (Report of a Case and Review of the Literature). In vivo (Athens, Greece), 2019 Jan-Feb;33(1):251-254
Stoner PL, Kamel A, Ayoub F, Tan S, Iqbal A, Glover SC, Zimmermann EM, Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional Support. Gastroenterology research and practice, 2018;2018:7890161
Stewart DC, Berrie D, Li J, Liu X, Rickerson C, Mkoji D, Iqbal A, Tan S, Doty AL, Glover SC, Simmons CS, Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease. PloS one, 2018;13(7):e0200377
Graves CL, Li J, LaPato M, Shapiro MR, Glover SC, Wallet MA, Wallet SM, Intestinal Epithelial Cell Regulation of Adaptive Immune Dysfunction in Human Type 1 Diabetes. Frontiers in immunology, 2016;7:679
Li J, Doty AL, Iqbal A, Glover SC, The differential frequency of Lineage(-)CRTH2(-)CD45(+)NKp44(-)CD117(-)CD127(+)ILC subset in the inflamed terminal ileum of patients with Crohn's disease. Cellular immunology, 2016 Jun-Jul;304-305:63-8
Li J, Doty A, Glover SC, Aryl hydrocarbon receptor signaling involves in the human intestinal ILC3/ILC1 conversion in the inflamed terminal ileum of Crohn's disease patients. Inflammation and cell signaling, 2016;3(3)
Yu HJ, Serebryannyy LA, Fry M, Greene M, Chernaya O, Hu WY, Chew TL, Mahmud N, Kadkol SS, Glover S, Prins G, Strakova Z, de Lanerolle P, Tumor stiffness is unrelated to myosin light chain phosphorylation in cancer cells. PloS one, 2013;8(11):e79776
Newsome RC, Gauthier J, Hernandez MC, Abraham GE, Robinson TO, Williams HB, Sloan M, Owings A, Laird H, Christian T, Pride Y, Wilson KJ, Hasan M, Parker A, Senitko M, Glover SC, Gharaibeh RZ, Jobin C, The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut microbes, 2021 Jan-Dec;13(1):1-15

Presentations

Poster Presentation, Hospitalization and Surgery Rates in Patients Awaiting Approval of Biologics or Small Molecules for, American College of Gastroenterology, Charlotte, NC10/2022
Poster Presentation, Hereditary Alpha Tryptasemia May Act as a Disease Modifier in Inflammatory Bowel Disease, American College of Gastroenterology, Charlotte, NC10/2022
Poster Presentation, Features of Environmental Dust Exposure Induced Lung Disease Regulated by MyD88 Result in a Prolonged Adaptation Response, American Academy of Allergy, Asthma & Immunology (AAAAI), Philadelphia, PA03/2020
Poster Presentation, E. COLI SEPSIS FOLLOWING FMT IN AN IGA DEFICIENT IBD SUBJECT, American College of Gastroenterology, San Antonio, Texas11/2019
Poster Presentation, REAL WORLD USE OF TACROLIMUS IN COMBINATION WITH BIOLOGICALS IS BENEFICIAL IN THE TREATMENT OF IBD, American College of Gastroenterology, San Antonio, Texas10/2019
Poster Presentation, INCREASED MUCOSAL INNATE IMMUNE ACTIVATION IN HEREDITARY ALPHA TRYTPASEMIA SUBJECTS IS PREDICTIVE OF CLINICAL RESPONSE TO TOFACITANIB THERAPY, American College of Gastroenterology, San Antonio, TX10/2019
Poster Presentation, Inhibition of Intestinal Epithelial Cell Pyroptosis and Associated Mucosal Barrier Defects is a Potential Therapeutic Mechanism of Action for Mesalamine in IBD, Digestive Disease Week, San Diego, CA05/2019
Poster Presentation, Identification of a Unique Population of GI Mast Cells in a Subset of Patients with Mast Cell Activation Syndrome, Digestive Disease Week, San Diego, CA05/2019
National and International Invited Seminars/Lectures, Ileal Biopsy Epithelial Cell Pyrotosis Predicts Clinical Response to Vedolizumab Therapy in Crohn’s Disease, Digestive Disease Week, San Diego, CA05/2019
Poster Presentation, Mast Cells in Patients with Hereditary α-Tryptasemia Promote HLA-DR Expression and a Th2-Polarizing Microenvironment in the Gastrointestinal Tract, American Association of Immunologists, San Diego, California05/2019
Poster Presentation, Predictors of 30 day readmission following major abdominal surgery for Crohn’s Disease, AMERICAN SOCIETY OF COLON AND RECTAL SURGEONS, Nashville, TN05/2018
Poster Presentation, Evaluating the impact of vedolizumab of postoperative complications in Inflammatory Bowel Disease Patients, American Society of Colon and Rectal Surgeons, Nashville, TN05/2018

Honors, Awards, and Recognition

Excellence in Research Gold Award, UMMC2022
Councilor, Southern Society for Clinical Investigation2021
Excellence in Research Silver Award, University of Mississippi Medical Center2020
Fred Allison, Jr MD Research Award, Department of Medicine University of Mississippi Medical Center2020
Fellow, Southern Society for Clinical Investigation2019
Category Award (Small Intestine) for Abstract Entitled: CD117+ Exosomes and Mast Cells From Hereditary Alpha Tryptasemia Patients Reveal Unique Phosphorylation, Lipidomics and Proteomics Profiles, American College of Gastroenterology2018
Fellow, American Gastroenterological Association2015
University of Illinois Hospital, Class Act Award2009
Stem Cell Conference Travel Award, American Gastroenterological Association2006
3rd Place, Fellow and Resident Research Competition, Chicago Society of Gastroenterology2003

Professional Membership and Service

Mississippi State Medical Association, Member2019 - Present
American Federation for Medical Research, Member2019 - Present
Southern Society for Clinical Investigation, Member2019 - Present
American Gastroenterological Association, Fellow2015 - Present
Clinical Immunology Society, Member2013 - Present
Federation of Clinical Immunology Societies, Member2013 - Present
American College of Gastroenterology, Member2013 - Present
Crohn's and Colitis Association of America, Member2012 - Present
American Osteopathic Association, Member2004 - Present

Committee Service

American Gastroenterological Association Research Scholar Award Review Panel 2020, Member2020 - 2020
Small Business Innovation Research Grant Applications in Digestive sciences Special Emphasis Panel Study Section, Member2020 - 2020

Community Service

Winterview Horse Farm Flora, MS, Sponsor08/2019 - Present

Directed Student Learning

Dissertation Committee Chair, Aberrant ILC Plasticity Contributes to Acute Campylobacteriosis and Chronic Intestinal Inflammation
Advised: Ying Tang
2015 - 2019
Dissertation Committee Chair, ABERRANT INNATE IMMUNITY CONTRIBUTES TO DYSREGULATED ADAPTIVE IMMUNE RESPONSES IN PATIENTS WITH CROHN’ S DISEASE
Advised: Jian Li
2012 - 2017
Dissertation Committee Chair, MECHANICAL MARKERS OF COLON CANCER A DIAGNOSTIC MODEL
Advised: Shruthi Bharadwaj
2009 - 2013
Master's Thesis Committee Chair2008 - 2010
Dissertation Committee Chair, The Role of ROCK in Colon Cancer Invasion Using Three-Dimensional Collagen I Microenvironments
Advised: Ramana Vishnubhotla
2008 - 2012
Master's Thesis Committee Chair, Advised: Rebecca Mecum2006 - 2008

Fellows supervised

University of Florida, Research Advisor, 4 fellows supervised, Gastroenterology08/2011 - 01/2020

Residency Training

Internal Medicine, Research Advisor2019 - 05/2019
Internal Medicine, Research Advisor2014 - 06/2016